GO:0070037 rRNA (pseudouridine) methyltransferase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0070037 describes the enzymatic transfer of a methyl group from S-adenosyl-L-methionine to a pseudouridine residue within ribosomal RNA, a conserved late step in ribosome assembly [3,4,5].
• The best-characterized enzyme carrying this activity is Nep1/Emg1, which catalyzes N1-methylation of pseudouridine 1248 in 18S rRNA and is essential for small ribosomal subunit biogenesis [3,4].
• In bacteria, RlmH (YbeA) performs an analogous m3Psi modification at nucleotide 1915 of 23S rRNA, demonstrating evolutionary conservation of pseudouridine methylation in the peptidyl transferase center [5,8].
• Loss of conserved rRNA modifications, including pseudouridine methylation, impairs protein synthesis and cell growth, linking this activity to translational fidelity.
• Mutations in EMG1 cause Bowen-Conradi syndrome, a severe ribosomopathy, highlighting the clinical importance of this enzymatic activity [3,4].
• Studying GO:0070037 requires combining structural biology, methyltransferase assays, and CRISPR-based models to dissect its role in ribosome function and disease [3,4,7].
Description
Ribosomal RNA is decorated with numerous chemical modifications that fine-tune ribosome assembly and translation. Among these, pseudouridine methylation represents a specialized modification catalyzed by enzymes annotated with the Gene Ontology term GO:0070037, rRNA (pseudouridine) methyltransferase activity [3,5]. This activity transfers a methyl group from S-adenosyl-L-methionine to a pseudouridine residue in rRNA, producing N1-methylpseudouridine or N3-methylpseudouridine depending on the enzyme and substrate position [3,5]. The importance of this modification is underscored by its conservation from bacteria to humans and its location within functionally critical regions of the ribosome, such as the peptidyl transferase center and the decoding site [5,7]. Researchers studying ribosome biogenesis, translation, and ribosomopathies have increasingly focused on pseudouridine methyltransferases because their loss leads to defective ribosome assembly and diminished protein synthesis [3,4,7]. The founding member of this enzyme class, Nep1/Emg1, is essential for 18S rRNA maturation and is mutated in Bowen-Conradi syndrome, a lethal developmental disorder [3,4]. In bacteria, RlmH (YbeA) methylates pseudouridine 1915 in 23S rRNA, and its deletion affects ribosome function and cell growth [5,8]. These findings establish GO:0070037 as a key activity linking RNA modification to translational control and human disease. This article provides a comprehensive overview of GO:0070037, covering its definition, molecular mechanism, key genes, regulatory context, disease associations, and state-of-the-art research methods. By integrating structural, biochemical, and genetic evidence, we aim to equip researchers with a practical framework for investigating this activity in health and disease.
rRNA (pseudouridine) methyltransferase activity At A Glance
| GO ID | GO:0070037 |
|---|---|
| GO term | rRNA (pseudouridine) methyltransferase activity |
| Ontology | molecular_function |
| Synonym | none |
| Major function | Methylation of pseudouridine residues in rRNA using S-adenosyl-L-methionine as methyl donor |
| Representative enzymes | Nep1/Emg1 (eukaryotic/archaeal), RlmH/YbeA (bacterial) |
| Substrate | Pseudouridine within rRNA (e.g., psi1248 in 18S rRNA, psi1915 in 23S rRNA) |
| Product | N1-methylpseudouridine or N3-methylpseudouridine in rRNA |
| Cofactor | S-adenosyl-L-methionine (SAM) |
| Biological context | Ribosome biogenesis, translation, and ribosomopathies |
What Is GO:0070037?
GO:0070037, rRNA (pseudouridine) methyltransferase activity, is defined as the catalysis of the transfer of a methyl group from S-adenosyl-L-methionine to a pseudouridine residue in an rRNA molecule [3,5]. In other words, it is an enzymatic activity that adds a methyl group specifically to pseudouridine within ribosomal RNA, generating methylated pseudouridine derivatives such as N1-methylpseudouridine or N3-methylpseudouridine [3,5]. This modification occurs post-transcriptionally during ribosome assembly and is distinct from other rRNA methylations that target standard nucleotides [3,5].
Why Is rRNA (pseudouridine) methyltransferase activity Important in Cell Biology?
GO:0070037 is critical because pseudouridine methylation in rRNA directly influences ribosome structure and function. The modification occurs at conserved positions within the ribosomal core, and its loss impairs subunit assembly, reduces translational capacity, and affects cell growth [3,4,7]. In humans, mutations in the enzyme responsible for this activity cause Bowen-Conradi syndrome, a severe ribosomopathy, demonstrating that precise pseudouridine methylation is essential for normal development [3,4]. Moreover, because ribosome biogenesis is tightly linked to cell proliferation, this activity has emerged as a potential target in cancer and other diseases characterized by deregulated translation.
• Essential for small ribosomal subunit assembly and 18S rRNA maturation in eukaryotes [3,4].
• Required for optimal protein synthesis and cell growth in yeast and bacteria [5,7].
• Mutations in EMG1, which encodes the pseudouridine methyltransferase, cause Bowen-Conradi syndrome [3,4].
• Contributes to translational fidelity by modifying the ribosomal decoding center.
• Represents a conserved mechanism of RNA modification across all domains of life [5,6].
• Potential biomarker or therapeutic target in ribosomopathies and cancer.
• Provides a model for studying enzyme-substrate recognition in RNA modification [3,4].
• Links rRNA modification to stress responses and cellular homeostasis [1,2].
What Happens During rRNA (pseudouridine) methyltransferase activity?
Recognition of pseudouridine within rRNA
In simple terms: The enzyme first finds and binds to a specific pseudouridine residue in the ribosomal RNA.
The enzymatic reaction begins with the methyltransferase recognizing its target pseudouridine within the context of a partially assembled ribosomal subunit. Structural studies of Nep1/Emg1 reveal that the enzyme uses a conserved binding pocket to flip the target nucleotide out of the rRNA helix, allowing access to the pseudouridine base [3,4]. This base-flipping mechanism is a common strategy in RNA-modifying enzymes and ensures specificity for the correct pseudouridine position, such as psi1248 in 18S rRNA [3,4]. In bacteria, RlmH (YbeA) similarly recognizes psi1915 in 23S rRNA, although the exact structural details may differ.
Methyl transfer from S-adenosyl-L-methionine
In simple terms: The enzyme takes a methyl group from a donor molecule and attaches it to the pseudouridine.
Once the target pseudouridine is properly positioned, the enzyme catalyzes the transfer of a methyl group from S-adenosyl-L-methionine (SAM) to the pseudouridine base. For Nep1/Emg1, this results in N1-methylpseudouridine, while RlmH produces N3-methylpseudouridine [3,5]. The reaction likely proceeds through a direct nucleophilic attack by the pseudouridine nitrogen on the methyl group of SAM, facilitated by conserved active-site residues. This step is highly specific and depends on the correct folding of the enzyme and the rRNA substrate [3,4].
Release of modified rRNA and recycling
In simple terms: After the methyl group is added, the modified rRNA is released and the enzyme can act again.
Following methyl transfer, the methylated pseudouridine is released from the active site, and the enzyme becomes available for another round of catalysis. The modified rRNA then continues along the ribosome assembly pathway, where the methyl group may stabilize local RNA structure or mediate specific RNA-protein interactions [3,4]. In yeast, loss of this modification leads to accumulation of assembly intermediates and reduced levels of mature ribosomal subunits. The enzyme itself is typically recycled and can modify multiple rRNA molecules.
Integration into ribosome assembly
In simple terms: The modified rRNA is incorporated into the growing ribosome, ensuring it works properly.
The pseudouridine methylation event occurs during the late stages of ribosome biogenesis, after the rRNA has been transcribed and processed but before the subunit is fully assembled. In eukaryotes, Emg1 acts in the small subunit processome, and its activity is required for the proper assembly of the 40S subunit [3,4]. In bacteria, RlmH modifies 23S rRNA within the large subunit, and the modification is thought to fine-tune the peptidyl transferase center [5,8]. Disruption of this step leads to defective ribosomes and impaired translation.
Key Genes Involved in GO:0070037 rRNA (pseudouridine) methyltransferase activity
The following genes encode enzymes or associated factors that carry out or regulate rRNA (pseudouridine) methyltransferase activity across species.
| Gene | Major Role | Research Relevance |
|---|---|---|
| EMG1 (NEP1) | Eukaryotic/archaeal N1-pseudouridine methyltransferase; methylates psi1248 in 18S rRNA | Mutations cause Bowen-Conradi syndrome; essential for 40S subunit assembly [3,4] |
| RLMH (YbeA) | Bacterial m3Psi methyltransferase; targets psi1915 in 23S rRNA | Model for studying pseudouridine methylation in the peptidyl transferase center [5,8] |
| RsmE | 16S rRNA m3U1498 methyltransferase | Structural and mechanistic insights into rRNA methylation |
| NEP1 (yeast) | Yeast ortholog of Emg1; required for 18S rRNA processing | Genetic studies of ribosome assembly and modification |
| EMG1 (human) | Human pseudouridine methyltransferase | Disease modeling and therapeutic target in ribosomopathies [3,4] |
| RLMH (E. coli) | E. coli RlmH; modifies 23S rRNA | Antibiotic target and translation studies |
| YbeA (E. coli) | Old name for RlmH | Historical and structural studies |
| Nep1 (archaea) | Archaeal Nep1; pseudouridine methyltransferase | Evolutionary conservation of rRNA modification |
| RlmH homologs | Widespread in bacteria | Comparative genomics and enzyme evolution |
| RsmE homologs | Bacterial 16S rRNA methyltransferases | Mechanistic studies of SAM-dependent methylation |
| NSUN family | m5C RNA methyltransferases | Related RNA modification enzymes; potential crosstalk |
| TRM proteins | tRNA methyltransferases | Comparative studies of RNA methylation |
| DIM1 | 18S rRNA methyltransferase (m6A) | Adjacent rRNA modification pathways |
| KsgA | 16S rRNA dimethyltransferase | Ribosome assembly and antibiotic resistance |
| RluA | Pseudouridine synthase | Generates pseudouridine substrates for methylation |
| Cbf5 | Pseudouridine synthase in H/ACA snoRNPs | Pseudouridine formation preceding methylation |
| Nop14 | Ribosome assembly factor | Couples modification to assembly |
| Utp proteins | Small subunit processome components | Context for Emg1 function |
How Is rRNA (pseudouridine) methyltransferase activity Regulated?
The activity of rRNA (pseudouridine) methyltransferases is regulated at multiple levels. Expression of EMG1 and other ribosome assembly factors is tightly coupled to cell growth and proliferation, often through nutrient-sensing pathways such as mTOR. In yeast, loss of pseudouridine methylation leads to feedback regulation of ribosome biogenesis, with accumulation of assembly intermediates triggering quality control pathways. Additionally, the activity may be influenced by the availability of S-adenosyl-L-methionine, the methyl donor, linking this modification to cellular metabolism. In plants, RNA-modifying enzymes, including those acting on rRNA, are responsive to stress and developmental signals, suggesting broader regulatory inputs. However, specific regulatory mechanisms for GO:0070037 remain an active area of research.
rRNA (pseudouridine) methyltransferase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| EMG1 | Bowen-Conradi syndrome | Patient-derived fibroblasts; Emg1 knockout mouse; yeast models [3,4] |
| RLMH | Bacterial growth and translation | E. coli deletion strains; ribosome profiling [5,7] |
| RsmE | 16S rRNA modification | Structural studies; in vitro methyltransferase assays |
| EMG1 (overexpression) | Cancer cell proliferation | Cancer cell lines with EMG1 knockdown/overexpression |
| NEP1 (yeast) | Ribosome assembly defects | S. cerevisiae nep1 mutants; polysome profiling [3,7] |
Bowen-Conradi syndrome
Bowen-Conradi syndrome is a severe autosomal recessive ribosomopathy caused by mutations in EMG1, the human gene encoding the pseudouridine methyltransferase Nep1/Emg1 [3,4]. Affected individuals present with microcephaly, growth retardation, and early lethality. The mutations impair the methyltransferase activity or stability of Emg1, leading to defective 18S rRNA processing and reduced small ribosomal subunit levels [3,4]. This disease exemplifies how loss of a single rRNA modification can have profound developmental consequences.
Cancer and translational deregulation
Deregulated ribosome biogenesis is a hallmark of cancer, and enzymes involved in rRNA modification, including pseudouridine methyltransferases, are often overexpressed in tumors to support increased protein synthesis. Although direct evidence for EMG1 in cancer is limited, the general principle that rRNA modifications contribute to translational capacity suggests that targeting GO:0070037 could be a therapeutic strategy. Loss of conserved rRNA modifications in yeast leads to diminished protein synthesis and cell growth, underscoring the potential impact on cancer cell proliferation.
Other ribosomopathies and developmental disorders
Beyond Bowen-Conradi syndrome, other ribosomopathies such as Diamond-Blackfan anemia and Shwachman-Diamond syndrome are linked to defects in ribosome assembly. While not directly caused by mutations in pseudouridine methyltransferases, these diseases highlight the sensitivity of developing tissues to impaired ribosome function [3,7]. Understanding GO:0070037 in the context of ribosome assembly may provide insights into the molecular basis of these disorders.
From rRNA (pseudouridine) methyltransferase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the catalytic mechanism of Emg1? | Point mutations in catalytic residues; in vitro methyltransferase assays [3,4] |
| How does loss of pseudouridine methylation affect translation? | Knockout of EMG1 in yeast or human cells; polysome profiling and Ribo-seq |
| Can we rescue Bowen-Conradi syndrome mutations? | Knock-in of patient mutations; overexpression of wild-type EMG1 [3,4] |
| Where is Emg1 localized during ribosome assembly? | Tagged knock-in of EMG1 with fluorescent protein; live-cell imaging |
| What are the downstream targets of RlmH? | Knockout of rlmH in E. coli; RNA modification mapping |
| Does pseudouridine methylation crosstalk with other modifications? | Overexpression of RluA and RlmH; mass spectrometry [6,8] |
How to Study the rRNA (pseudouridine) methyltransferase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| In vitro methyltransferase assay | Enzymatic activity using radioactive SAM | Characterization of enzyme kinetics and substrate specificity [3,5] |
| Ribo-seq | Ribosome occupancy and translational efficiency | Global effects of rRNA modification on translation |
| Polysome profiling | Distribution of ribosomes on mRNAs | Assessment of translation initiation and elongation |
| LC-MS/MS | Mass and abundance of modified nucleosides | Detection of methylated pseudouridine in rRNA [5,8] |
| RiboMethSeq | Position and stoichiometry of rRNA methylation | Mapping of modification sites |
| X-ray crystallography | Three-dimensional structure of enzyme-RNA complexes | Mechanistic insights into catalysis [4,8] |
| CRISPR knockout | Gene function by loss-of-function | Studying essentiality of methyltransferases [3,7] |
| Live-cell imaging | Subcellular localization and dynamics | Tracking enzyme during ribosome assembly |
Methyltransferase activity assays
In vitro methyltransferase assays using recombinant enzyme and synthetic rRNA fragments containing pseudouridine are the gold standard for measuring GO:0070037 activity. These assays typically use tritiated S-adenosyl-L-methionine and measure incorporation of radioactivity into the RNA substrate [3,5]. Such assays can be adapted for high-throughput screening to identify inhibitors or activators. Structural studies using X-ray crystallography or cryo-EM complement these assays by revealing the atomic details of substrate binding and catalysis [4,8].
Ribosome profiling and polysome analysis
Ribosome profiling (Ribo-seq) and polysome profiling are powerful methods to assess the impact of pseudouridine methylation on translation. By comparing wild-type and mutant cells, researchers can quantify changes in ribosome occupancy and translational efficiency. These techniques have been used to show that loss of conserved rRNA modifications leads to diminished protein synthesis and cell growth in yeast. Combining Ribo-seq with RNA-seq provides a comprehensive view of how rRNA modification affects gene expression.
Mass spectrometry and RNA modification mapping
Mass spectrometry-based methods, such as LC-MS/MS, allow direct detection and quantification of methylated pseudouridine in rRNA. These approaches can map the exact position of modifications and assess stoichiometry [5,8]. They are particularly useful for validating the specificity of methyltransferases and for studying crosstalk between different rRNA modifications. Advanced techniques like RiboMethSeq can also provide positional information on rRNA methylation.
CRISPR-based genetic screens
CRISPR knockout and knock-in screens enable systematic interrogation of genes involved in rRNA modification. By generating loss-of-function mutations in EMG1, RLMH, and related genes, researchers can study their roles in ribosome assembly and cell viability [3,7]. CRISPR interference (CRISPRi) and activation (CRISPRa) can further modulate gene expression to fine-tune the levels of methyltransferases. These tools are essential for linking genotype to phenotype in the context of GO:0070037.
How CRISPR Can Be Used to Study GO:0070037 rRNA (pseudouridine) methyltransferase activity
Knockout
CRISPR knockout of EMG1 or RLMH provides a powerful way to study the loss of pseudouridine methyltransferase activity. In human cells, EMG1 knockout leads to defective 18S rRNA processing and impaired proliferation, mimicking aspects of Bowen-Conradi syndrome [3,4]. In bacteria, rlmH deletion strains show altered ribosome function and reduced growth. These models are invaluable for dissecting the cellular consequences of GO:0070037 loss.
Point Mutation
Introducing point mutations that abolish catalytic activity or mimic patient mutations allows precise interrogation of the enzymatic mechanism. For example, mutations in the active site of Emg1 can distinguish between defects in catalysis versus substrate binding [3,4]. Such point-mutant cell lines are essential for understanding structure-function relationships and for validating drug targets.
Knock-in
Knock-in of tagged or fluorescently labeled EMG1 enables real-time tracking of the enzyme during ribosome assembly. This approach can reveal dynamic localization and interactions with other assembly factors. Knock-in of disease-associated mutations also provides a platform for testing therapeutic interventions.
Overexpression
Overexpression of wild-type or mutant methyltransferases can be used to study gain-of-function effects and to produce large quantities of enzyme for biochemical assays. In cancer research, overexpression of EMG1 may model the increased ribosome biogenesis observed in tumors. Controlled overexpression systems allow titration of enzyme levels to study dose-dependent effects on translation.
How EDITGENE Supports rRNA (pseudouridine) methyltransferase activity Research
Researchers studying rRNA (pseudouridine) methyltransferase activity-related genes often need to determine whether a candidate gene is causally involved in ribosome assembly, translation, or disease. Generating precise genetic models is essential to move from correlation to causation. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for rRNA (pseudouridine) methyltransferase activity research.
Frequently Asked Questions About rRNA (pseudouridine) methyltransferase activity
What is rRNA (pseudouridine) methyltransferase activity?
It is an enzymatic activity defined by GO:0070037 that transfers a methyl group from S-adenosyl-L-methionine to a pseudouridine residue in ribosomal RNA, producing methylated pseudouridine [3,5].
What genes are involved in rRNA (pseudouridine) methyltransferase activity?
Key genes include EMG1 (NEP1) in eukaryotes and RLMH (YbeA) in bacteria, along with related enzymes such as RsmE [3,4,5,8].
Which enzyme catalyzes N1-methylpseudouridine formation in 18S rRNA?
Nep1/Emg1 is the enzyme responsible for N1-methylation of pseudouridine 1248 in 18S rRNA [3,4].
What is the role of Emg1 in ribosome assembly?
Emg1 is essential for small ribosomal subunit biogenesis; its methyltransferase activity modifies 18S rRNA and facilitates proper assembly [3,4].
How is rRNA pseudouridine methylation linked to disease?
Mutations in EMG1 cause Bowen-Conradi syndrome, a severe ribosomopathy characterized by developmental defects [3,4].
What methods are used to study rRNA (pseudouridine) methyltransferase activity?
Common methods include in vitro methyltransferase assays, Ribo-seq, polysome profiling, mass spectrometry, and CRISPR-based genetic screens [3,5,7,8].
What is the difference between pseudouridine synthase and pseudouridine methyltransferase?
Pseudouridine synthases convert uridine to pseudouridine, while pseudouridine methyltransferases add a methyl group to the already formed pseudouridine.
Can CRISPR be used to model Bowen-Conradi syndrome?
Yes, CRISPR knockout or knock-in of EMG1 mutations in cell lines or animal models can recapitulate aspects of the disease [3,4].
What is the bacterial equivalent of Emg1?
In bacteria, RlmH (YbeA) performs a similar pseudouridine methylation at position 1915 in 23S rRNA.
Why is pseudouridine methylation important for translation?
It modifies the ribosome's functional core, and its loss impairs protein synthesis and cell growth.
Conclusion
GO:0070037, rRNA (pseudouridine) methyltransferase activity, represents a critical enzymatic step in ribosome biogenesis that ensures proper translation. The conserved nature of this modification, from bacteria to humans, underscores its fundamental importance. Dysregulation of this activity leads to severe diseases such as Bowen-Conradi syndrome, and emerging evidence links it to cancer and other ribosomopathies. Continued research using advanced CRISPR models and multi-omics approaches will further illuminate the mechanistic details and therapeutic potential of targeting this activity.
References
- 1. Saraumi M et al.. 2025. RNA processing/modifying enzymes play key roles in the response to thermospermine in Arabidopsis thaliana.. Plant J 123(5):e70476 PMID: 40946342
- 2. Moon J et al.. 2025. NSUN-Mediated m5C RNA Modification in Stem Cell Regulation.. Cells 14(20) PMID: 41148823
- 3. Wurm JP et al.. 2010. The ribosome assembly factor Nep1 responsible for Bowen-Conradi syndrome is a pseudouridine-N1-specific methyltransferase.. Nucleic Acids Res 38(7):2387-98 PMID: 20047967
- 4. Thomas SR et al.. 2011. Structural insight into the functional mechanism of Nep1/Emg1 N1-specific pseudouridine methyltransferase in ribosome biogenesis.. Nucleic Acids Res 39(6):2445-57 PMID: 21087996
- 5. Purta E et al.. 2008. YbeA is the m3Psi methyltransferase RlmH that targets nucleotide 1915 in 23S rRNA.. RNA 14(10):2234-44 PMID: 18755835
- 6. Ofengand J et al.. 2001. Pseudouridines and pseudouridine synthases of the ribosome.. Cold Spring Harb Symp Quant Biol 66:147-59 PMID: 12762017
- 7. Leppik M et al.. 2024. Loss of Conserved rRNA Modifications in the Peptidyl Transferase Center Leads to Diminished Protein Synthesis and Cell Growth in Budding Yeast.. Int J Mol Sci 25(10) PMID: 38791231
- 8. Zhang H et al.. 2012. Insights into the catalytic mechanism of 16S rRNA methyltransferase RsmE (m³U1498) from crystal and solution structures.. J Mol Biol 423(4):576-89 PMID: 22925577
